Spiking Dependence of SARS-CoV-2 Pathogenicity on TMPRSS2

    February 2021 in “ Journal of Medical Virology
    Asim Z. Abbasi, Dania A. Kiyani, Syeda M. Hamid, Muhammad Saalim, Ammad Fahim, Nasir Jalal
    TLDR TMPRSS2 affects COVID-19 severity and treatment options.
    This review explored the role of the Transmembrane Serine Protease 2 (TMPRSS2) in influencing the susceptibility and pathogenicity of SARS-CoV-2 across different population groups. It highlighted that the cleavage of the viral spike protein by TMPRSS2 is crucial for viral entry into host cells, and variations in the expression of the TMPRSS2 gene among ethnic groups could impact COVID-19 infection rates and outcomes. The review also discussed potential treatments involving TMPRSS2 protease blockers and inhibitors as promising strategies for managing COVID-19.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results